Aehr Test Systems (AEHR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Aehr Test Systems stock (AEHR) is currently trading at $39.19. Aehr Test Systems PS ratio (Price-to-Sales) is 19.85. Analyst consensus price target for AEHR is $36.33. WallStSmart rates AEHR as Sell.
- AEHR PE ratio analysis and historical PE chart
- AEHR PS ratio (Price-to-Sales) history and trend
- AEHR intrinsic value — DCF, Graham Number, EPV models
- AEHR stock price prediction 2025 2026 2027 2028 2029 2030
- AEHR fair value vs current price
- AEHR insider transactions and insider buying
- Is AEHR undervalued or overvalued?
- Aehr Test Systems financial analysis — revenue, earnings, cash flow
- AEHR Piotroski F-Score and Altman Z-Score
- AEHR analyst price target and Smart Rating
Aehr Test Systems
📊 No data available
Try selecting a different time range
Smart Analysis
Aehr Test Systems (AEHR) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, institutional own.. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Aehr Test Systems (AEHR) Key Strengths (2)
Growing significantly faster than its price suggests
70.88% of shares held by major funds and institutions
Supporting Valuation Data
Aehr Test Systems (AEHR) Areas to Watch (8)
Company is destroying shareholder value
Losing money on operations
Revenue declining -26.50%, a shrinking business
Earnings declining -87.50%, profits shrinking
Company is losing money with a negative profit margin
Very expensive at 19.9x annual revenue
Very expensive at 8.1x book value
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Aehr Test Systems (AEHR) Detailed Analysis Report
Overall Assessment
This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 10 metrics analyzed, 2 register as strengths (avg 10.0/10) while 8 fall into concern territory (avg 1.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Institutional Own.. Valuation metrics including PEG Ratio (0.90) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (19.85), Price/Book (8.08) suggest expensive pricing. Growth concerns include Revenue Growth at -26.50%, EPS Growth at -87.50%, which may limit upside. Profitability pressure is visible in Return on Equity at -6.97%, Operating Margin at -49.20%, Profit Margin at -16.60%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -6.97% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -26.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AEHR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AEHR's Price-to-Sales ratio of 19.85x trades 290% above its historical average of 5.09x (96th percentile), historically expensive. The current valuation is 18% below its historical high of 24.13x set in Mar 2026, and 2819% above its historical low of 0.68x in Apr 2009.
Compare AEHR with Competitors
Top SEMICONDUCTOR EQUIPMENT & MATERIALS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Aehr Test Systems (AEHR) · TECHNOLOGY › SEMICONDUCTOR EQUIPMENT & MATERIALS
The Big Picture
Aehr Test Systems is in a turnaround phase, with management focused on restoring profitability. Revenue reached 53M with 27% decline year-over-year. The company is currently unprofitable, posting a -16.6% profit margin.
Key Findings
Debt-to-equity ratio of 0.08 indicates a conservative balance sheet with 31M in cash.
Revenue contracted 27% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -16.6% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 2.31, so expect amplified moves relative to the broader market.
Sector dynamics: monitor SEMICONDUCTOR EQUIPMENT & MATERIALS industry trends, competitive moves, and regulatory changes that could impact Aehr Test Systems.
Bottom Line
Aehr Test Systems is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(36 last 3 months)
| Insider | Type | Shares |
|---|---|---|
SCOTT, GEOFFREY GATES Director | Sell | -5,104 |
| Insider | Type | Shares |
|---|---|---|
WIMMERS, DIDIER Executive VP of R&D | Sell | -364 |
| Insider | Type | Shares |
|---|---|---|
SIU, CHRIS CFO | Sell | -368 |
| Insider | Type | Shares |
|---|---|---|
POSEDEL, RHEA J Director | Sell | -13,998 |
| Insider | Type | Shares |
|---|---|---|
SLAYEN, HOWARD T Director | Sell | -5,000 |
| Insider | Type | Shares |
|---|---|---|
SALAMONE, ALBERTO EVP, PPBI BUSINESS | Sell | -234 |
| Insider | Type | Shares |
|---|---|---|
SPORCK, ALISTAIR N VP Contactor Business Unit | Sell | -387 |
Data sourced from SEC Form 4 filings
Last updated: 8:25:12 AM
About Aehr Test Systems(AEHR)
NASDAQ
TECHNOLOGY
SEMICONDUCTOR EQUIPMENT & MATE...
USA
Aehr Test Systems primarily designs, designs, manufactures and sells test and burn equipment for use in the semiconductor industry in the United States, Asia and Europe. The company is headquartered in Fremont, California.